Correction to: Cell Death and Disease (2012) 3, e339; doi:10.1038/cddis.2012.80; published online 5 July 2012
Since the publication of this article the authors have noticed that Giovanna De Chiara’s affiliation address was incorrect. The error has now been rectified. The article with the corrected authors list and affiliations appears online, together with this corrigendum.
The authors would like to apologize for this error.
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found at 10.1038/cddis.2012.80
Rights and permissions
About this article
Cite this article
Scarpi, D., Cirelli, D., Matrone, C. et al. Erratum: Low molecular weight, non-peptidic agonists of TrkA receptor with NGF-mimetic activity. Cell Death Dis 3, e389 (2012). https://doi.org/10.1038/cddis.2012.129
Published:
Issue Date:
DOI: https://doi.org/10.1038/cddis.2012.129
This article is cited by
-
3β, 6β-dichloro-5-hydroxy-5α-cholestane facilitates neuronal development through modulating TrkA signaling regulated proteins in primary hippocampal neuron
Scientific Reports (2019)
-
Advances in developing novel therapeutic strategies for Alzheimer’s disease
Molecular Neurodegeneration (2018)
-
Theoretical grounds and technologies for dipeptide drug development
Russian Chemical Bulletin (2015)
-
Small-molecule modulation of neurotrophin receptors: a strategy for the treatment of neurological disease
Nature Reviews Drug Discovery (2013)
